martes, 27 de octubre de 2015

National Guideline Clearinghouse | Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index.

full-text ►

National Guideline Clearinghouse | Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index.



National Institute for Health and Care Excellence (NICE)

National Guideline Clearinghouse (NGC)

Guideline Title
Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index.
Bibliographic Source(s)
National Institute for Health and Care Excellence (NICE). Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index. London (UK): National Institute for Health and Care Excellence (NICE); 2015 Jun 2. 50 p.  (Diagnostics guidance; no. 17).
Guideline Status
This is the current release of the guideline.
This guideline meets NGC's 2013 (revised) inclusion criteria.

No hay comentarios:

Publicar un comentario